Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06632496 · ClinicalTrials.gov registry record
BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study
A clinical trial of BD Prevue II for Peripheral Intravenous Catheter Placement, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- 156
- Enrollment target
- 2
- Study locations
NCT06632496 is a study of BD Prevue II for Peripheral Intravenous Catheter Placement that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 156 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06632496, a study of BD Prevue II for Peripheral Intravenous Catheter Placement, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- 156 participants
- Enrollment target
- 2
- Study locations
Study Summary
This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.
Conditions Studied
Interventions
- DEVICE BD Prevue(TM) II
Study Locations (2)
New York
- Brookdale University Hospital & Medical Center - Brooklyn
Pennsylvania
- Allegheny Health Network Research Institute - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2025-03-28 |
| Est. Completion | 2025-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06632496
The ClinicalTrials.gov registry entry for NCT06632496 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with BD Prevue II for Peripheral Intravenous Catheter Placement appearing as the primary indexed condition, and to 1 intervention - of which BD Prevue(TM) II is the first listed.
NCT06632496 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06632496 about?
NCT06632496 is a clinical study titled "BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study". This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual...
What is the current status of trial NCT06632496?
This trial is currently completed. The enrollment target is 156 participants. The study started on 2025-03-28. Estimated completion is 2025-09-23.
What conditions does trial NCT06632496 study?
This clinical trial studies the following conditions: BD Prevue II for Peripheral Intravenous Catheter Placement.
What interventions are being tested in trial NCT06632496?
The interventions under investigation include: BD Prevue(TM) II (DEVICE).
Who is sponsoring clinical trial NCT06632496?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06632496 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.